Name: UMIN ID:
Unique ID issued by UMIN | UMIN000024580 |
---|---|
Receipt number | R000028290 |
Scientific Title | Effect of concomitant use of formula diet with dapagliflozin on body compositions, metabolic improvement, and its safety in type 2 diabetes mellitus. |
Date of disclosure of the study information | 2017/03/01 |
Last modified on | 2019/11/05 12:48:49 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/10/27 10:45:41 | ||
2 | Update | 2016/10/31 09:56:54 | Public title Acronym Acronym |
|
3 | Update | 2016/12/01 14:14:53 | Division name Date of disclosure of the study information |
|
4 | Update | 2016/12/01 14:18:14 | Acronym Acronym |
|
5 | Update | 2016/12/01 14:19:05 | Date of protocol fixation Anticipated trial start date |
|
6 | Update | 2017/03/18 17:44:29 | Condition Condition |
|
7 | Update | 2017/03/18 17:48:14 | Key exclusion criteria Key exclusion criteria |
|
8 | Update | 2017/03/18 17:57:42 | Primary outcomes Primary outcomes |
|
9 | Update | 2017/03/18 19:02:38 | Key secondary outcomes Key secondary outcomes |
|
10 | Update | 2017/03/21 15:02:49 | Institutions |
|
11 | Update | 2017/03/21 15:08:53 | Recruitment status |
|
12 | Update | 2017/03/21 15:44:40 | Anticipated trial start date |
|
13 | Update | 2017/03/21 18:41:12 | Recruitment status |
|
14 | Update | 2017/03/22 08:04:27 | Key secondary outcomes |
|
15 | Update | 2017/03/22 08:10:23 | Key secondary outcomes |
|
16 | Update | 2018/07/09 12:50:55 | Recruitment status |
|
17 | Update | 2019/05/15 08:59:08 | URL releasing protocol Number of participants that the trial has enrolled Results |
|
18 | Update | 2019/05/15 09:01:18 | Recruitment status Date of IRB Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
19 | Update | 2019/11/05 12:48:49 | Publication of results URL related to results and publications |